Hpspitals Segment to Dominate SAM SPECT Equipment Market during 2021–2028

According to a new market research study on “SAM SPECT Equipment Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type, Radioisotopes, Application, and End User” is expected to reach US$ 144.47 million by 2028 from US$ 112.52 million in 2021. The market is estimated to grow at a CAGR of 3.6% from 2021 to 2028. The report provides trends prevailing in the SAM SPECT equipment market along with the drivers and restraints pertaining to the market growth. Rise in incidence of cardiovascular diseases is the major factor driving the growth of the SAM SPECT equipment market. However, issues associated with the high cost hinder the growth of SAM SPECT equipment market.

The SAM SPECT equipment market has been segmented based on type, radioisotopes, application, end user, and country. Based on type, the SAM SPECT equipment market is segmented into hybrid SPECT and standalone SPECT. The hybrid SPECT segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Further, hybrid SPECT is bifurcated by SPECT-CT and SPECT-MR. Based on radioisotopes, the SAM SPECT equipment market is segmented into Iodine-123, Technetium-99m, Xenon-133, Thallium-201, Radium-223, Gallium-66, and other radioisotopes. The Technetium-99m segment dominated the market in 2020 and Ga-66 segment is expected to be the fastest growing during the forecast period. Based on application, the SAM SPECT equipment market is segmented into seizures, stroke, stress fractures, infections, tumors, and others. The stroke segment dominated the market in 2020 and tumors is expected to be the fastest growing during the forecast period. Based on end user, the SAM SPECT equipment market is segmented into hospitals, imaging centers, and others. The hospitals dominated the market in 2020 and imaging centers segment is expected to be the fastest growing during the forecast period. Based on country, the SAM SPECT equipment market is classified into Brazil, Argentina, and Rest of SAM.

Imaging methods have played a prominent role in the diagnosis of coronavirus disease 2019 (COVID-19) and in the follow-up of patients with the disease. Chest computed tomography (CT) has always been the protagonist of this process, and various radiological societies were efficient in disseminating consensus statements about the use of imaging methods for the diagnosis of COVID-19. Although polymerase chain reaction (PCR) is the gold standard for the diagnosis of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), computed tomography is an alternative for situations in which it is necessary to make immediate decisions. A study wherein 155 patients with suspected COVID-19 treated at Pedro Ernesto University Hospital between March and May 2020 was approved by the Institutional Review Board of Pedro Ernesto University Hospital, operated by Rio de Janeiro State University, in the city of Rio de Janeiro, Brazil as all the data points were acquired from the hospitals residing in the concerned region. The inclusion criteria were being greater than 18 years of age, presenting with acute respiratory symptoms, and having had contact with COVID-19 patients or individuals with symptoms suggestive of the disease, with or without laboratory confirmation of SARS-CoV-2 infection. The usage of SPECT equipment or the inclusion of computer-aided technology had an overall favorable impact in the region and the same is expected to propel the global industry growth. Such a factor is expected to favor the global SPECT equipment market over the next eight years.

Bracco Imaging S.p.A.; Bruker Corporation; Cardinal Health, Inc; Curium; Lantheus Medical Imaging Inc.; and Spectrum Dynamics Medical are among the leading companies in the SAM SPECT Equipment market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Cardinal Health Nuclear & Precision Health Solutions received U.S. Food and Drug Administration approval for new LYMPHOSEEK Pediatric Indication.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com